184 related articles for article (PubMed ID: 34307308)
21. Angiotensin II type 1 receptor antagonist attenuates lacrimal gland, lung, and liver fibrosis in a murine model of chronic graft-versus-host disease.
Yaguchi S; Ogawa Y; Shimmura S; Kawakita T; Hatou S; Satofuka S; Nakamura S; Imada T; Miyashita H; Yoshida S; Yaguchi T; Ozawa Y; Mori T; Okamoto S; Kawakami Y; Ishida S; Tsubota K
PLoS One; 2013; 8(6):e64724. PubMed ID: 23762250
[TBL] [Abstract][Full Text] [Related]
22. Angiopoietin-like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytes.
Wang S; Li Y; Miao W; Zhao H; Zhang F; Liu N; Su G; Cai X
Mol Med Rep; 2016 Sep; 14(3):2607-13. PubMed ID: 27483989
[TBL] [Abstract][Full Text] [Related]
23. Novel regulatory effect of angiotensin II type 1 receptor-interacting molecule on vascular smooth muscle cells.
Azuma K; Tamura K; Shigenaga A; Wakui H; Masuda S; Tsurumi-Ikeya Y; Tanaka Y; Sakai M; Matsuda M; Hashimoto T; Ishigami T; Lopez-Ilasaca M; Umemura S
Hypertension; 2007 Nov; 50(5):926-32. PubMed ID: 17875818
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
[TBL] [Abstract][Full Text] [Related]
25. AT
Bernhem K; Krishnan K; Bondar A; Brismar H; Aperia A; Scott L
BMC Cardiovasc Disord; 2017 May; 17(1):126. PubMed ID: 28514967
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin II type 1 receptor variants alter endosomal receptor-β-arrestin complex stability and MAPK activation.
Cao Y; Kumar S; Namkung Y; Gagnon L; Cho A; Laporte SA
J Biol Chem; 2020 Sep; 295(38):13169-13180. PubMed ID: 32703898
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II activates Ca
Kashihara T; Nakada T; Kojima K; Takeshita T; Yamada M
J Physiol; 2017 Jul; 595(13):4207-4225. PubMed ID: 28295363
[TBL] [Abstract][Full Text] [Related]
28. Intraperitoneal Administration of Telmisartan Prevents Postsurgical Adhesion Band Formation.
Arjmand MH; Zahedi-Avval F; Barneh F; Mousavi SH; Asgharzadeh F; Hashemzehi M; Soleimani A; Avan A; Fakhraie M; Nasiri SN; Mehraban S; Ferns GA; Ryzhikov M; Jafari M; Khazaei M; Hassanian SM
J Surg Res; 2020 Apr; 248():171-181. PubMed ID: 31923833
[TBL] [Abstract][Full Text] [Related]
29. Type-1 angiotensin receptor signaling in central nervous system myeloid cells is pathogenic during fatal alphavirus encephalitis in mice.
Blakely PK; Huber AK; Irani DN
J Neuroinflammation; 2016 Aug; 13(1):196. PubMed ID: 27562117
[TBL] [Abstract][Full Text] [Related]
30. Genetic code expansion and photocross-linking identify different β-arrestin binding modes to the angiotensin II type 1 receptor.
Gagnon L; Cao Y; Cho A; Sedki D; Huber T; Sakmar TP; Laporte SA
J Biol Chem; 2019 Nov; 294(46):17409-17420. PubMed ID: 31530642
[TBL] [Abstract][Full Text] [Related]
31. A Novel Angiotensin II-Induced Long Noncoding RNA Giver Regulates Oxidative Stress, Inflammation, and Proliferation in Vascular Smooth Muscle Cells.
Das S; Zhang E; Senapati P; Amaram V; Reddy MA; Stapleton K; Leung A; Lanting L; Wang M; Chen Z; Kato M; Oh HJ; Guo Q; Zhang X; Zhang B; Zhang H; Zhao Q; Wang W; Wu Y; Natarajan R
Circ Res; 2018 Dec; 123(12):1298-1312. PubMed ID: 30566058
[TBL] [Abstract][Full Text] [Related]
32. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
[TBL] [Abstract][Full Text] [Related]
33. Evaluating the benefits of renin-angiotensin system inhibitors as cancer treatments.
Perini MV; Dmello RS; Nero TL; Chand AL
Pharmacol Ther; 2020 Jul; 211():107527. PubMed ID: 32173557
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin II reduces mitochondrial content in skeletal muscle and affects glycemic control.
Mitsuishi M; Miyashita K; Muraki A; Itoh H
Diabetes; 2009 Mar; 58(3):710-7. PubMed ID: 19074984
[TBL] [Abstract][Full Text] [Related]
35. Biased Agonism of the Angiotensin II Type I Receptor.
Ikeda Y; Kumagai H; Motozawa Y; Suzuki J; Komuro I
Int Heart J; 2015; 56(5):485-8. PubMed ID: 26180022
[TBL] [Abstract][Full Text] [Related]
36. Recent Research Advances in Renin-Angiotensin-Aldosterone System Receptors.
Azushima K; Morisawa N; Tamura K; Nishiyama A
Curr Hypertens Rep; 2020 Feb; 22(3):22. PubMed ID: 32114685
[TBL] [Abstract][Full Text] [Related]
37. Arsenite Induces Vascular Endothelial Cell Dysfunction by Activating IRE1α/XBP1s/HIF1α-Dependent ANGII Signaling.
Xu X; Liu S; Aodengqimuge ; Wang H; Hu M; Xing C; Song L
Toxicol Sci; 2017 Dec; 160(2):315-328. PubMed ID: 28973481
[TBL] [Abstract][Full Text] [Related]
38. Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension.
Rincón J; Correia D; Arcaya JL; Finol E; Fernández A; Pérez M; Yaguas K; Talavera E; Chávez M; Summer R; Romero F
Life Sci; 2015 Mar; 124():81-90. PubMed ID: 25623850
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II removes kidney resistance conferred by ischemic preconditioning.
Jang HS; Kim JI; Kim J; Park JW; Park KM
Biomed Res Int; 2014; 2014():602149. PubMed ID: 25243156
[TBL] [Abstract][Full Text] [Related]
40. Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities.
Saavedra JM
Cell Mol Neurobiol; 2005 Jun; 25(3-4):485-512. PubMed ID: 16075377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
